Jiangsu Yuwell Technology Development Co., Ltd. (“Yuwell Technology”) successfully completed its acquisition of 51.51% interest in CR Wandong Medical Equipment Co., Ltd. (“CR Wandong”, 600055) and 100% interest in Shanghai Medical Equipment (Group) Co., Ltd. (“SMEG”) on Apr. 9, 2015. Yuwell Technology acquired 51.51% interest in CR Wandong from Beijing Pharmaceutical Group Co., Ltd. (“Beijing Pharma”) and 100% interest in SMEG from CR Pharmaceutical Investment Co., Ltd. The total consideration is RMB 1.833Bn in cash (RMB 1.142Bn for CR Wandong and RMB 691 million for SMEG). CICC acted as Financial Advisor of Yuwell Technology in this transaction.